Uncategorized

Post Archives


Member Feature – Bravo Group

Bravo Group is the 40th-largest independent public relations firm in the United States and Pennsylvania’s largest independent public relations firm, serving clients within the commonwealth and around the world. Bravo Group is a strategic communications firm operating at the intersection of public affairs and marketing, with a proven approach that reflects the firm’s understanding of complex industries and the changing environment of marketing and communications. With roots in advocacy, their singular focus is delivering the win to their clients. That’s why Bravo Group’s teams are organized around the win, not in siloed disciplines. Some talk integration — they live it. Bravo Group partners with clients at every step, operating with integrity and delivering results. Specifically, their in-house capabilities span research and insights, strategic planning, compelling creative, digital marketing and media buying, public and media relations, coalition building, government relations and lobbying, analytics and measurement, and digital technology teams. Bravo Group’s solutions are grounded in data science but designed for humans, which gives their clients an edge to win tough fights. Founded in 1999 in Harrisburg, Pennsylvania, as a one-person shop, the organization has now expanded with offices in Philadelphia and Pittsburgh, and presences in Washington, D.C., Texas and the United Kingdom.


Member Feature – Mazars

Mazars is an international audit, tax and advisory firm committed to helping clients confidently build and grow their businesses. As the independent US firm of Mazars Group, Mazars in the US has roots going back to 1921, and a significant national presence in strategic geographies, providing seamless access to 24,000 professionals in 90+ countries and territories around the world. Mazars works as a single, integrated team, committed to helping clients and people succeed by respecting who they are and how they work, adapting their approach accordingly. The Firm takes pride in what they do and they are committed to playing their part in building the economic foundations of a fair and prosperous world. Mazars industry specialists deliver tailored services to a wide range of clients across sectors, including individuals, high-growth emerging companies, privately-owned businesses and large enterprises. The Firm always seeks to understand their clients and their environments, adjusting recommendations and support accordingly. Experience a different way of working. Find out more at Mazars.us.


Member Feature – The Philadelphia Union

The Philadelphia Union is an innovative, forward-thinking professional soccer club competing in Major League Soccer (MLS) and one of Philadelphia’s five major league sports teams. Driven by unprecedented fan support, MLS awarded the Philadelphia expansion franchise rights to Jay Sugarman in 2008 and the Union kicked off its inaugural season in 2010. The club has reached the finals of the Lamar Hunt U.S. Open Cup in 2014, 2015 and 2018, and has appeared in the MLS Cup Playoffs in 2011, 2016, 2018 and 2019. In 2020, the Union were awarded the club’s first Supporters’ Shield after finishing with the best regular season record in MLS. The Philadelphia Union is part of parent company Keystone Sports and Entertainment LLC, which also operates USL Championship side Philadelphia Union II, the Philadelphia Union Academy, Philadelphia Union Foundation and Philadelphia Union Youth Programs. With a commitment to developing talent from the Delaware Valley, the Union has signed nine local players from their academy to a first team contract. The Union play at Subaru Park in Chester, PA on the banks of the Delaware River. The custom-built stadium is part of the Union’s unique waterfront campus, featuring a historic power plant rebuilt into a 400,000 sq. ft. creative office building, a state-of-the-art Training Complex, over 7 acres of professional-grade practice pitches and multiple onsite parking fields. Philadelphia was awarded Major League Soccer’s 16th team on February 28, 2008. Led by the ownership group of Keystone Sports and Entertainment, LLC, the club operated under the name MLS Philadelphia 2010 for most of 2008 and the early portion of 2009. The combination of extensive grassroots support spearheaded by the Sons of Ben and a public/private partnership between Philadelphia Union, the State of Pennsylvania, Delaware County and the City of Chester enabled the construction of a state-of-the-art soccer stadium and convinced MLS that the Philadelphia region deserved a soccer team. The BABCPHL has partnered with Philadelphia Union since its inception, collaborating on events, cross-promotional opportunities, and VIP game experiences. We are grateful for the partnership, and we look forward to many more seasons together!


Member Feature – Office of International Business Development

The Department of Community and Economic Development’s mission is to encourage the shared prosperity of all Pennsylvanians by supporting good stewardship and sustainable development initiatives across our commonwealth. With a keen eye toward diversity and inclusiveness, we act as advisors and advocates, providing strategic technical assistance, training, and financial resources to help our communities and industries flourish. Pennsylvania’s Office of International Business Development (OIBD) is committed to supporting Pennsylvania companies by working with them to increase their export sales and attracting foreign companies to invest in Pennsylvania. OIBD’s Export Development program reduces the cost, risk and time traditionally associated with international market exploration. By partnering with a Regional Export Network and managing a global network of Authorized Trade Representatives, OIBD provides unrivaled services and expertise for both new-to export companies and experienced exporters seeking new markets. OIBD’s Investment staff and its network of eight investment contractors work closely with the Governor’s Action Team (GAT), local governments, and economic development agencies around the commonwealth to promote Pennsylvania as a compelling business investment location for international companies. OIBD, an agency within the Department of Community and Economic Development, is a long-time partner and supporter of the BABCPHL. We are proud to collaborate with them on both sides of the Atlantic. Special thanks to David Briel, Richard Kilner, Declan Barry and their team for their work in strengthening ties with the United Kingdom, which is Pennsylvania’s leading investor and fifth largest trading partner.


Member Feature – Shout Digital

Shout Digital is a software innovator. They specialize in digital products and experiences, using research, analysis and insights coupled with technology and creativity to solve business challenges. Shout Digital is a UK company with offices in London and Newcastle, where they have been operating for more than a decade. Philadelphia is home to Shout Digital’s US headquarters. The Company’s ethos is “staying ahead of the curve to ensure you remain relevant and competitive in your marketplace as it evolves.” Shout Digital remains true to themselves and their clients by building long-lasting working relationships based on three core values – honesty, integrity and pride. The Company is driven to make a difference, solving clients’ business problems and delivering digital experiences audiences will love. Upon arrival to Philadelphia, Shout Digital became engaged with the BABCPHL. We are honored to recognize Shout Digital’s cutting-edge work and their involvement with and dedication to the BABCPHL.


Winter 2021 Human Interest Feature – Penn Medicine

Still Thriving Years After Groundbreaking Cancer Immunotherapy
Experts Gather this Spring to Share Progress and Chart Future Course

Their options had run out. Multiple rounds of chemotherapy had proven ineffective. The cancer could not be contained. This scenario is familiar to many oncologists and other medical specialists who treat diseases for which there is no cure. Patients face the news with emotions ranging from fear, sadness, hopelessness to determination and, in some cases, bravery.

Doug Olson, a leukemia survivor, rejects the notion of bravery. “When you’re told that you are out of options and you see an opportunity, that’s your focus. Hope is the most important thing for cancer patients – to have the opportunity to fight back. It’s a big part of the consideration when you make a decision to do something that has never been done before.”

Olson speaks from experience. In 2010, he was patient number two to receive an experimental therapy developed at Penn Medicine’s Abramson Cancer Center. The treatment, known as CAR T-cell therapy, was an entirely new form of immunotherapy.

For years, University of Pennsylvania scientist Carl June, MD, and colleagues had pursued the vision of a cancer therapy that would work by reengineering T cells (the immune system’s fighters). Unlike chemotherapy that attacks all fast-growing cells, immunotherapy works with the body’s best defense – the immune system. During CAR T-cell therapy, a patient’s immune cells, or T cells, are reengineered – they are removed, genetically modified so they can recognize and kill tumor cells, and returned to the body to find and destroy the cancer cells.

After a 1996 chronic lymphocytic leukemia diagnosis, Olson endured multiple rounds of chemotherapy with sporadic periods of remission until the cancer no longer responded. His doctor, David Porter, MD, at Penn’s Abramson Cancer Center, presented Olson with the option to join a new clinical trial for a treatment not yet tested in people. It would be a risk but June, along with Bruce Levine, PhD, Porter, and others had worked relentlessly towards this goal for years. It was time. Olson’s willingness to be person number two on this trial changed his life and the course of cancer treatment. One month after the T cell infusion, there was no evidence of leukemia by any test the doctors performed.

Then, in 2012, Emily Whitehead became the first pediatric patient to enroll in a pediatric clinical trial testing the same treatment. At age 5, Emily was diagnosed with acute lymphoblastic leukemia (ALL). Her parents brought her to Children’s Hospital of Philadelphia’s (CHOP’s) top-ranked cancer center where she received care from a team led by Stephan Grupp, MD, PhD, the oncologist leading the study at CHOP, and colleagues who specialized in hard-to-treat blood cancers. ALL is often treatable in children but, in Emily’s case, the disease failed to respond to any chemotherapy. A bone marrow transplant would be the next step toward a cure, but she needed to respond to treatment before that could happen, and she wasn’t responding. Transplant wasn’t possible.

At CHOP, Emily’s parents were introduced to the idea of treating their daughter with the innovative new therapy being tested in adults right next door at the Hospital of the University of Pennsylvania. With hospice as their only other option, they were desperate for their daughter to join the phase 1 trial of CAR T-cell therapy. The trial opened at the exact moment Emily needed it. Everyone involved rushed the paperwork and processes to collect her cells and enroll her in the trial.

Emily’s treatment went smoothly until she was admitted to the hospital with an extreme immune response beyond what had been seen in the handful of adults treated before her. The response, now known as cytokine release syndrome, ravaged Emily’s young body through the night. Desperate for solutions, June suggested a new arthritis drug designed to target a specific cytokine observed at high levels in CAR T patients. Miraculously, it worked.

Three weeks later, like Doug Olson, Emily Whitehead was cancer-free. This early trial led to the 2017 approval of the drug tisagenlecleucel (Kymriah®) to treat particularly tough ALL in children and young adults. Kymriah is unique in that it is a living drug. Years beyond treatment, many patients remain in remission and still retain powerful T cells in their bodies.

A scientist and a businessman, Doug Olson now lives a full life, an opportunity afforded him by the miracle of CAR T-cell therapy. Emily Whitehead is a teenager who is passionate about school (she’s a straight “A” student), art, healthy living goals, and her dog Luna. When asked what stands out, Olson reflects, “the fact that I’m alive and that what I participated in has literally changed the landscape of cancer treatment.”

Today, doctors study CAR T-cell therapy in cancers ranging from pancreas to melanoma to brain. Research also explores why the approach works better for some patients than others, and how to deliver the therapy out of the hospital and more safely. CAR T-cell therapy is just one kind of cellular therapy being studied at Penn and CHOP. Its approval has unleashed a floodgate of related research on other delivery mechanisms beyond CAR. Doctors and scientists on Penn/CHOP team have won many prestigious awards for this work, including June’s 2018 nomination for a Nobel prize.

In 2019, the Penn’s Abramson Cancer Center and CHOP hosted a large international gathering of doctors and scientists dedicated to cellular therapy. Nearly 1,000 medical and biotech professionals arrived in Philadelphia to hear from pioneers in the field who played pivotal roles in the work leading up to the approval of CAR T-cell therapy.

This May, Drs. June, Grupp, Levine and Porter will once again bring together experts from around the globe, this time virtually, to share findings and chart a future course for cellular gene therapies. Members of industry and advocates will join physicians, nurses, scientists and others for a two-day program. Highlights will include a keynote talk by Stanley Riddell, MD, of the Fred Hutchinson Cancer Research Center on “Engineering Smarter T Cells.” Dr. Riddell is a world leader in developing immunotherapies and the architect of groundbreaking work to develop longer-lasting T cells. General and breakout sessions will also cover critical topics such as current uses, globalization, gene delivery and editing, overcoming resistance, and new targets and technologies. An exhibit hall will showcase the state-of-the-art discoveries that are advancing the field.

Cellicon Valley ’21: The Future of Cell and Gene Therapies
Virtual Symposium
May 6 – May 7, 2021
Hosted by Penn Medicine’s Abramson Cancer Center and Children’s Hospital of Philadelphia
Register now – https://www.med.upenn.edu/cellicon2021/


BABCPHL Winter 2021 New Members

Corporate Members:

Buchanan Ingersoll & Rooney, PC
Two Liberty Place
50 South 16th Street
Suite 3200
Philadelphia PA 19102
Website: https://www.bipc.com/

Craig D. Mills
Executive Shareholder
P: 215.665.3863
E: craig.mills@bipc.com

Buchanan Ingersoll & Rooney is a national law firm with a proven reputation for providing progressive, industry-leading legal, business, regulatory and government relations advice to our regional, national and international clients. Our 450 attorneys and government relations professionals across 15 offices proudly represent some of the highest profile and innovative companies in the nation, including 50 of the Fortune 100.

Mazars USA LLP
501 Office Center Dr.
Suite 300
Fort Washington PA 19034
Website: mazars.us

Jim Welsh
Pennsylvania Office Managing Partner
P: 267-532-4462
E: Jim.Welsh@mazarsusa.com

Jacqueline Barnard
Marketing Manager
E: Jacqueline.Barnard@mazarsusa.com

Mazars is an international audit, tax and advisory firm committed to helping clients confidently build and grow their businesses. As the independent US firm of Mazars Group, Mazars in the US has roots going back to 1921, and a significant national presence in strategic geographies, providing seamless access to 24,000 professionals in 90+ countries and territories around the world. Mazars works as a single, integrated team, committed to helping clients and people succeed by respecting who they are and how they work, adapting their approach accordingly. The Firm takes pride in what they do and they are committed to playing their part in building the economic foundations of a fair and prosperous world. Mazars industry specialists deliver tailored services to a wide range of clients across sectors, including individuals, high-growth emerging companies, privately-owned businesses and large enterprises. The Firm always seeks to understand their clients and their environments, adjusting recommendations and support accordingly. Experience a different way of working.

London & Partners
902 Broadway
New York NY 10010
Website: londonandpartners.com

Stephen Feline
Vice President, US East Coast
e: sfeline@londonandpartners.com

London & Partners is the international trade, investment and promotion agency for London. It is our role to promote London internationally as a leading world city in which to visit, study, invest, grow and meet.

We promote London across the world; attract overseas organisations, events, students and visitors to the capital; and help to retain and grow London companies. Our key international markets are North America, China, France, Germany and India.

Find out about our different business areas, from business development, leisure tourism and insights, to higher education and major events. Learn more about what London & Partners delivers for London.

Pennsylvania Department of Community & Economic Development
Keystone Building
400 North Street, 4th Floor
Harrisburg PA 17120
Website: dced.pa.gov

David Briel
Executive Director Foreign Direct Investment
Office of International Business Development
P: 717-720-7373
E: dbriel@pa.gov

Michael O’Rourke
Deputy Secretary
PA Department of Community & Economic Development
Office of International Business Development
P: 717-720-7446
E: miorourke@pa.gov

Jennifer Black
Executive Director, Export Development
Office of International Business Development
P: 717-720-7472
E: Jblack@pa.gov

The mission of the Department of Community and Economic Development (DCED) is to foster opportunities for businesses to grow and for communities to succeed and thrive in a global economy. Our mission is to improve the quality of life for Pennsylvania citizens while assuring transparency and accountability in the expenditure of public funds.

With one of the largest networks of overseas consultancy offices of any state in the U.S., Pennsylvania’s Office of International Business Development (OIBD) is committed to supporting Pennsylvanian companies by working with them to increase their export sales and encouraging foreign companies to invest in Pennsylvania.

Export Development: OIBD’s Export Development program reduces the cost, risk and time traditionally associated with international market exploration. By partnering with a

Regional Export Network and managing a global network of Authorized Trade Representatives, OIBD provides unrivaled services and expertise for both new-to export companies and experienced exporters seeking new markets.

OIBD’s Investment staff and its network of 8 investment contractors work closely with the Governor’s Action Team (GAT), local governments, and economic development agencies around the state to promote Pennsylvania as a compelling business investment location for international companies.

Individual Member:

William M. Smith
Manager, Tax
Wipfli LLP
170 North Radnor-Chester Road
Suite 200
Radnor PA 19087
P: 484-445-0576
F: 484-428-3296
E: bill.smith@wipfli.com
Website: wipfli.com


Winter 2021 President’s Letter

Dear BABCPHL Members and Friends,

This calendar year marks our 30th Anniversary.  I’d like to thank our Board of Directors, members and staff, for enabling us to reach this milestone.

BABCPHL Board Members are leaders in their fields that volunteer their time, ideas and money to ensure the viability and longevity of our Organization. Along with the support of our staff, Jane Rosenberg, Executive Director, and Brianna Adams, Coordinator, the Board is responsible for guiding the Organization to meet the needs of our Members.  By leveraging the company’s that they represent, our Board Members enhance transatlantic business throughout the region we serve, and are often the featured experts in our programs.

We are truly grateful to each and every one of our Members. Thank you for contributing to our success throughout the years and for your continued interest and support.

It is during trying times like these that a group will sink or swim.  As we near the one-year mark of the start of the pandemic in the US, we remain afloat. However, to maintain our stability we are keenly aware of the need to focus on strategic development plans for our future.

We understand it is going to take more than virtual events to maintain our momentum and remain true to our mission. This month we commenced our members only matchmaking meetings. Each group was carefully curated. The BABCPHL is a connector organization, and we are proud to fulfill our mission by facilitating individual introductions among members to enhance the trade and commercial relationship between the Greater Philadelphia region and the UK.

We have several exciting things planned from now through the end of our fiscal year in June. Visit our website often for the latest news and information about our upcoming events.

If you are not a member and you wish to learn more, please contact us. We look forward to continuing to serve you for many more years. Thank you for helping us strengthen the UK-Greater Philadelphia partnership for the past three decades and counting!

Sincerely,

Nick Lotz

President, British American Business Council of Greater Philadelphia


Member Feature – Bartlett Group

Bartlett Group is a boutique international insurance broker with more than 80 years of experience helping global businesses manage risk.  As a third-generation family owned business, Bartlett has grown organically from a one-man office in the North of England to a multinational broker with offices in the United States, United Kingdom, Continental Europe, Africa, Asia and Australia.  Operating in more than 40 countries, serving regional manufacturing and technology firms to large publicly-listed multinational companies, as well as private clients, Bartlett’s international presence and experience uniquely position them to handle complex multinational insurance programs.  In 1995 Bartlett Group founded the Bartlett Foundation.  Every year they give 8% of their pre-tax profits to charities and organizations that support the education and welfare of young people, particularly in the developing world. Two times in the last five years Bartlett Group has won nationally acclaimed industry awards.  We are honored to call Bartlett Group one of our founding member companies, and to recognize them as members for the past 30 years.


BABCPHL New Year Greetings

Dear BABCPHL Members and Friends,

Happy New Year! I hope this message finds you and your loved ones well. This year marks the BABCPHL’s 30th anniversary. We have been operating in this region since 1991, and we look forward to partnering with you in 2021 and beyond. Please visit our website and contact us with questions about our upcoming activities and membership.

2020 was a whirlwind, culminating with British lawmakers voting to back the United Kingdom’s post-Brexit trade deal with the European Union, marking the end of the transition period. This historic vote happened in the midst of the surging pandemic which continues to evolve and envelop our world. Despite this tragedy, time marches on and with it the hope of vaccine distribution, and continued negotiations for a US-UK Free Trade Agreement. The UK and the US share a historic bond. We are allies through thick and thin. The BABCPHL is proud to be the premier British business organization in our region that you and your transatlantic enterprise can rely on for valuable networking opportunities and timely trade and commercial information.

We thank you for your partnership and look forward to continued collaboration to strengthen our relationship with Great Britain. Cheers to a healthy, safe and prosperous New Year!

Sincerely,

Nick Lotz
President, British American Business Council of Greater Philadelphia

↑ back to top


The BABCPHL recognizes our Club Level Members:

  • Almac
  • American Airlines
  • Cigna
  • Cigna
  • Duane Morris
  • EisnerAmper LLP
  • Faegre Drinker Biddle & Reath LLP
  • Fisher Phillips
  • HSBC
  • International Products Corporation
  • Johnson, Kendall & Johnson, Inc.
  • KPMG
  • Morgan Lewis
  • Welsh Government